The Helsinki approach to face transplantation.


Journal

Journal of plastic, reconstructive & aesthetic surgery : JPRAS
ISSN: 1878-0539
Titre abrégé: J Plast Reconstr Aesthet Surg
Pays: Netherlands
ID NLM: 101264239

Informations de publication

Date de publication:
02 2019
Historique:
received: 11 05 2018
revised: 12 08 2018
accepted: 30 08 2018
pubmed: 4 10 2018
medline: 8 11 2019
entrez: 4 10 2018
Statut: ppublish

Résumé

We herein describe the establishment of the Helsinki Vascularized Composite Allotransplantation (VCA) program and its execution in the first two face transplant cases. The Helsinki VCA program initially required the fulfillment of legal, hospital, financial, and ethical requirements. Thereafter, the assembling of a multidisciplinary team commenced. A team of Plastic, maxillofacial and ENT surgeons comprise the facial VCA team. The protocol involves collaboration with the Solid Organ Transplant (SOT) team, transplant immunology, immunosuppression, microbiology, psychiatric evaluation, well-defined VCA indications and informed consent. Between 2011 and 2017 two patients were selected for transplantation. Both patients had a severe composite facial deformity involving the maxilla and mandible following earlier ballistic injury. Patient 1 was a 35 year-old male who underwent successful near total face transplantation in February 2016 and at 30 months he has a good aesthetic outcome with symmetrical restoration of the central face and good sensory and symmetrical motor functional outcomes. Patient 2 was a 58 year-old male who underwent full face transplantation in March 2018 and at 5 months he has recovered without major problems. A successful facial VCA program requires a well-prepared research protocol, experts from multiple specialties and careful patient selection. The establishment of the Helsinki VCA program required long and thorough planning and resulted in the first two Nordic face transplantation cases. This protocol now forms the platform (as a proof of concept) for other types of vascularized composite allotransplantations.

Identifiants

pubmed: 30279107
pii: S1748-6815(18)30336-X
doi: 10.1016/j.bjps.2018.08.030
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

173-180

Informations de copyright

Copyright © 2018 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Auteurs

Andrew J Lindford (AJ)

Department of Plastic Surgery, Töölö Hospital, Helsinki University Hospital (HUS), University of Helsinki, Topeliuksenkatu 5, P.O. Box 266, FIN-00029, Helsinki, Finland. Electronic address: andrew.lindford@hus.fi.

Heikki Mäkisalo (H)

Transplantation and Liver Surgery Clinic, Helsinki University Hospital, University of Helsinki, Finland.

Hannu Jalanko (H)

Department of Pediatric Nephrology and Transplantation, Children's Hospital, Helsinki University Hospital, Finland.

Jouni Lauronen (J)

Finnish Red Cross Blood Service, Helsinki, Finland.

Veli-Jukka Anttila (VJ)

Department of Infectious Diseases, Helsinki University Hospital, University of Helsinki, Finland.

Susanna Juteau (S)

Department of Pathology, Haartman Institute, University of Helsinki & HUSLAB, Helsinki, Finland.

Antti-Jussi Ämmälä (AJ)

Department of Psychiatry, Helsinki University Hospital, University of Helsinki, Finland.

Anna Eskola (A)

Department of Psychiatry, Helsinki University Hospital, University of Helsinki, Finland.

Samuli Saarni (S)

Department of Health, Unit of Mental Health, National Institute for Health and Welfare, Helsinki, Finland; Turku University Hospital, University of Turku, Turku, Finland.

Helena Isoniemi (H)

Transplantation and Liver Surgery Clinic, Helsinki University Hospital, University of Helsinki, Finland.

Antti Mäkitie (A)

Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.

Patrik Lassus (P)

Department of Plastic Surgery, Töölö Hospital, Helsinki University Hospital (HUS), University of Helsinki, Topeliuksenkatu 5, P.O. Box 266, FIN-00029, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH